Carmen Chang

Insider Reports History

Location
2855 Sand Hill Road, Menlo Park, CA
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carmen Chang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 7.69M $146M $19.00 Jun 28, 2021 Indirect
Savara Inc 10%+ Owner Common Stock 24.5M $109M $4.45 Jul 17, 2023 Indirect
Korro Bio, Inc. 10%+ Owner Common Stock 1.09M $61.1M $56.00 Apr 22, 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Common Stock 3.61M $38.6M $10.69 Sep 16, 2024 Indirect
Coursera, Inc. Director Common Stock 2.21M $19.3M $8.75 May 21, 2025 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 949K $1.92M $2.02 Apr 11, 2022 Indirect
Metacrine, Inc. 10%+ Owner Common Stock 2.56M $1.2M $0.47 Dec 22, 2021 Indirect
Coursera, Inc. Director Common Stock 88.3K $772K $8.75 May 21, 2025 Direct
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 135 $3.79K $28.04 Jun 13, 2023 Direct
NeueHealth, Inc. Director, 10%+ Owner Common Stock 0 $0 $6.84 Oct 2, 2025 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants 3M Apr 11, 2022 Indirect
Akouos, Inc. 10%+ Owner Common Stock 0 $12.50 Nov 30, 2022 Indirect
GENOCEA BIOSCIENCES, INC. 10%+ Owner Common Stock 0 $1.25 May 25, 2022 Indirect
MBX Biosciences, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Sep 16, 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Sep 16, 2024 Indirect
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 0 $28.04 Jun 13, 2023 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series A-2 convertible preferred stock 0 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 $2.00 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series C convertible preferred Stock 0 Jun 28, 2021 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series A Convertible Perpetual Preferred Stock 0 Oct 2, 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series B Convertible Perpetual Preferred Stock 0 Oct 2, 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Warrant (Right to Buy) 0 Oct 2, 2025 Indirect

Insider Reports Filed by Carmen Chang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NEUE NeueHealth, Inc. Oct 2, 2025 31 $14.80 4 Oct 6, 2025 Director, 10%+ Owner
COUR Coursera, Inc. May 21, 2025 1 $0 4 May 23, 2025 Director
NEUE NeueHealth, Inc. Oct 1, 2024 3 $0 4 Oct 3, 2024 10%+ Owner
MBX MBX Biosciences, Inc. Sep 16, 2024 5 $8M 4 Sep 17, 2024 10%+ Owner
MBX MBX Biosciences, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 10%+ Owner
COUR Coursera, Inc. May 22, 2024 1 $0 4 May 24, 2024 Director
KRRO Korro Bio, Inc. Apr 22, 2024 1 $1M 4 Apr 24, 2024 10%+ Owner
NEUE NeueHealth, Inc. Apr 8, 2024 3 $0 4 Apr 10, 2024 10%+ Owner
BHG Bright Health Group Inc. Dec 19, 2023 1 $0 4 Dec 21, 2023 10%+ Owner
FREQ Korro Bio, Inc. Nov 3, 2023 0 $0 3 Nov 7, 2023 10%+ Owner
BHG Bright Health Group Inc. Oct 31, 2023 1 $0 4 Nov 2, 2023 10%+ Owner
BHG Bright Health Group Inc. Sep 15, 2023 1 $0 4 Sep 19, 2023 10%+ Owner
BHG Bright Health Group Inc. Aug 11, 2023 1 $0 4 Aug 15, 2023 10%+ Owner
SVRA Savara Inc Jul 17, 2023 1 $1M 4 Jul 19, 2023 10%+ Owner
MIRM Mirum Pharmaceuticals, Inc. Jun 13, 2023 4 $0 4 Jun 15, 2023 10%+ Owner
COUR Coursera, Inc. May 24, 2023 1 $0 4 May 26, 2023 Director
COUR Coursera, Inc. Mar 15, 2023 1 -$14.5K 4 Mar 17, 2023 Director
COUR Coursera, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 Director
AKUS Akouos, Inc. Nov 30, 2022 1 $0 4 Dec 2, 2022 10%+ Owner
BHG Bright Health Group Inc. Oct 17, 2022 2 $138M 4 Oct 19, 2022 10%+ Owner
GNCA GENOCEA BIOSCIENCES, INC. May 24, 2022 2 -$751K 4 May 26, 2022 10%+ Owner
COUR Coursera, Inc. May 13, 2022 1 $0 4 May 16, 2022 Director
TRVI Trevi Therapeutics, Inc. Apr 11, 2022 3 $12.5M 4 Apr 13, 2022 10%+ Owner
BHG Bright Health Group Inc. Jan 3, 2022 2 $200M 4 Jan 5, 2022 10%+ Owner
MTCR Metacrine, Inc. Dec 10, 2021 3 -$494K 4 Dec 27, 2021 10%+ Owner
COUR Coursera, Inc. Nov 1, 2021 1 $0 4 Nov 3, 2021 Director
TRVI Trevi Therapeutics, Inc. Oct 18, 2021 3 $0 4 Oct 19, 2021 10%+ Owner
COUR Coursera, Inc. Oct 12, 2021 0 $0 3 Oct 12, 2021 Director
BHG Bright Health Group Inc. Jun 28, 2021 12 $35M 4 Jun 30, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 28, 2021 7 $20M 4 Jun 30, 2021 10%+ Owner
BHG Bright Health Group Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 10%+ Owner